RxDoctor Payments Data

Nasreen Ahmad, PA

Physician Assistant · Bronx, NYNPI 1679117824

Payments from drug & device makers

$3,513in general payments, 2019–2025

Across 132 payments — averaging $26.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$543
  • Bayer$381
  • Lilly USA, LLC$343
  • Merck$263
  • Axsome Therapeutics, Inc.$257
  • Johnson & Johnson$251
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,513100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,513 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$5,558
Medicare patients
29
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin25$20,594
FarxigaDapagliflozin Propanediol22$14,276
TrulicityDulaglutide15$13,347
Diclofenac Sodium20$10,623
VascepaIcosapent Ethyl12$5,785
Atorvastatin Calcium54$517
Alcohol Prep PadsAlcohol Antiseptic Pads32$442
Albuterol Sulfate HfaAlbuterol Sulfate11$387
Rosuvastatin Calcium15$315
Tamsulosin Hcl32$286
Metoprolol Succinate24$269
Lisinopril33$237
ClopidogrelClopidogrel Bisulfate20$223
Levothyroxine Sodium35$207
Glipizide29$189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$543$20,59425 claims
AstraZenecaFarxiga$234$14,27622 claims
Lilly USA, LLCTrulicity$343$13,34715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →